Head and neck cancer, Malignant mesothelioma, Osteo sarcoma, TGF-β signal transduction, CTGF, Molecular target therapy, Heavy-ion radiation therapy, Translational research
The field of genomic medicine has experienced rapid progression since the completion of the Human Genome Project in 2003. Many diseases have been shown to derive from genomic abnormalities, and research based on the knowledge of human genome is predicted to lead to new insights in advancing our understanding of human disease.
Currently, one in two individuals dies from cancer in Japan, whereas outcomes with cancer treatments have improved due to remarkable progress in technology. New diagnostic techniques and therapeutic approaches are developed based on global research in genomic medicine and tumor biology. The long-term effort of researchers around the globe has led to the development of many successful therapies for patients with cancer, and more innovations in cancer treatment are expected in future.